Publication & Citation Trends
Publications
0 total
CARD19, a Novel Regulator of the TAK1/NF-κB Pathway in Self-Reactive B Cells. OA
Cited by 1
Semantic Scholar
91-LB: COVALENT-111, a Phase 1/2 Trial of BMF-219, a Covalent Menin Inhibitor, in Patients with Type 2 Diabetes Mellitus—Preliminary Results
Cited by 3
Semantic Scholar
Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell Lymphoma Entities in the Routine Clinical Practice OA
Cited by 23
Semantic Scholar
GRN300–001: Phase 1/1B evaluation of the safety, pharmacokinetics, and efficacy of GRN-300, a salt-inducible kinase inhibitor, alone and in combination with paclitaxel, in recurrent ovarian, primary peritoneal, and fallopian tube cancers.
Cited by 2
Semantic Scholar
Relieving DYRK1A repression of MKL1 confers an adult-like phenotype to human infantile megakaryocytes OA
Cited by 10
Semantic Scholar
Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients Without Pathologic Complete Response After Neoadjuvant Systemic Chemotherapy OA
Cited by 23
Semantic Scholar
Abstract 1720: Ax-101, an immunostimulatory small molecule, markedly enhances the antitumor activity of PD1 immune checkpoint blockade in multiple preclinical solid tumor models
Cited by 0
Semantic Scholar
CARD19, a Novel Negative Regulator of B-Cell Tolerance OA
Cited by 0
Semantic Scholar
Research Topics
Lymphoma Diagnosis and Treatment
(54)
Lung Cancer Treatments and Mutations
(26)
Chronic Lymphocytic Leukemia Research
(25)
Immune Cell Function and Interaction
(15)
Cancer-related Molecular Pathways
(14)
Affiliations
University of Toledo Medical Center
Brigham and Women's Hospital
Centre National de la Recherche Scientifique
St. Jude Children's Research Hospital
The University of Texas MD Anderson Cancer Center